Adenomyosis is a disease where ectopic endometrial-like glands affect the muscular wall of the uterus. About 70% of women affected by adenomyosis suffer from dysmenorrhea and menorrhagia. A levonorgestrel-releasing intrauterine device (LNG-IUD) is the first-choice treatment of adenomyosis, but is not always sufficiently effective in all women. Those women often end up removing the uterus (hysterectomy).

Hysterectomy is clinically regarded to be an efficient and final treatment of adenomyosis, but pelvic pain may also prevail after removal of the uterus. This study aimes to investigate the short - and long-term impact of hysterectomy on quality of life (QOL) and sexual function in women with adenomyosis, and further to evaluate if there is any difference compared to women that are removing their uterus due to other benign gynecological conditions.

Inclusion Criteria:

• Premenopausal status defined by having had menstruation within the last 12 months, or age < 50 years if amenorrhea due to hormonal treatment
• Hysterectomy planned due to a benign condition
• Able to communicate in Norwegian or English
• Electronic consent given

Exclusion Criteria:

• Age < 18 years, postmenopausal status or no menstrual bleeding for the last 12 months
• Hysterectomy as part of female-to-male transition
• Pelvic organ prolapse as an indication for hysterectomy
• Gynecological cancer suspected at the time of inclusion
• Not able to communicate in Norwegian or English

A consecutive sample of women that are scheduled for hysterectomy at the study site, who fulfill eligibility criteria, are invited to participate

We will share the values of the quality of life data.

The data is planned to be made available within a year after the publication of all results.

Access will be granted upon request and evaluation of the intended use of the data. The intended use should primarily gain improved patient care and research into quality of life after hysterectomy and a detailed protocol has to be submitted.